SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-22-001917
Filing Date
2022-05-12
Accepted
2022-05-12 08:03:27
Documents
37
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q zk2227758.htm   iXBRL 10-Q 706114
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 13218
3 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 13586
4 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 5179
5 EXHIBIT 32.2 exhibit_32-2.htm EX-32.2 5578
  Complete submission text file 0001178913-22-001917.txt   3173682

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE entx-20220331.xsd EX-101.SCH 44251
7 XBRL CALCULATION FILE entx-20220331_cal.xml EX-101.CAL 28869
8 XBRL DEFINITION FILE entx-20220331_def.xml EX-101.DEF 66980
9 XBRL LABEL FILE entx-20220331_lab.xml EX-101.LAB 736265
10 XBRL PRESENTATION FILE entx-20220331_pre.xml EX-101.PRE 163709
31 EXTRACTED XBRL INSTANCE DOCUMENT zk2227758_htm.xml XML 203118
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38556 | Film No.: 22915777
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences